Levofloxacin

Paul G. Auwaerter, M.D., Edina Avdic, Pharm.D.

INDICATIONS

FDA

NON-FDA

  • Treatment of M. tuberculosis, including MDR and XDR-TB (in combination with other agents)
  • Treatment of MAI and other non-TB mycobacterial infections (in combination with other agents)
  • Alternative therapy for treating S. pneumoniae and H. influenzae meningitis in patients with severe penicillin allergies.
  • Bone and joint infections
  • Intra-abdominal infections in combination with metronidazole
  • H. pylori, in combination with other agents
  • Prophylaxis in neutropenic patients

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 18, 2022